Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Immuneering Corp as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −5 vs. Q2 2022
- Shares held
- 12.1M
- −85.5K (−0.7%) vs. Q2 2022
- Total value
- $172.5M
- +$106.8M (+162.5%) vs. Q2 2022
- New holders
- 5
- 9 more added
- Sold out
- 10
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 38 | $1.00K | 0.00% | −853−95.7% | Reduced |
| Daiwa Securities Group Inc. | 76 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 105 | $2.00K | 0.00% | −1,296−92.5% | Reduced |
| China Universal Asset Management Co., Ltd. | 247 | $4.00K | 0.00% | +247 | New |
| JPMorgan Chase & Co | 1,143 | $16.0K | 0.00% | +10+0.9% | Added |
| Wells Fargo & Company | 1,121 | $16.0K | 0.00% | +1,066+1,938.2% | Added |
| Tower Research Capital LLC (TRC) | 2,717 | $39.0K | 0.00% | −111−3.9% | Reduced |
| Citigroup Inc | 4,209 | $60.0K | 0.00% | +3,280+353.1% | Added |
| Barclays PLC | 4,590 | $65.0K | 0.00% | +430+10.3% | Added |
| Millennium Management LLC | 10,264 | $147.0K | 0.00% | −118,389−92.0% | Reduced |
| Balyasny Asset Management LLC | 11,366 | $163.0K | 0.00% | +11,366 | New |
| Morgan Stanley | 11,749 | $168.0K | 0.00% | −6,538−35.8% | Reduced |
| Goldman Sachs Group Inc | 11,828 | $169.0K | 0.00% | −6,756−36.4% | Reduced |
| Qube Research & Technologies Ltd | 13,315 | $191.0K | 0.00% | −2,627−16.5% | Reduced |
| State Street Corp | 29,135 | $417.0K | 0.00% | +4,100+16.4% | Added |
| Gsa Capital Partners LLP | 33,110 | $474.0K | 0.06% | +33,110 | New |
| Northern Trust Corp | 34,660 | $496.0K | 0.00% | +18,977+121.0% | Added |
| Bridgeway Capital Management, LLC | 34,949 | $500.0K | 0.01% | 00.0% | Unchanged |
| Kore Private Wealth LLC | 58,649 | $840.0K | 0.15% | −375−0.6% | Reduced |
| Marshall Wace, LLP | 67,160 | $962.0K | 0.00% | +67,160 | New |
| Adage Capital Partners GP, L.L.C. | 75,000 | $1.07M | 0.00% | −10,000−11.8% | Reduced |
| Manufacturers Life Insurance Company, The | 82,536 | $1.08M | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 147,661 | $1.94M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 169,591 | $2.43M | 0.00% | +94,991+127.3% | Added |
| Buckingham Strategic Wealth, LLC | 200,200 | $2.87M | 0.06% | 00.0% | Unchanged |
| FMR LLC | 223,014 | $3.19M | 0.00% | −140−0.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 458,233 | $6.56M | 0.01% | +458,233 | New |
| Vanguard Group Inc | 818,489 | $11.7M | 0.00% | +77,866+10.5% | Added |
| BlackRock Inc. | 1,424,034 | $20.4M | 0.00% | +67,364+5.0% | Added |
| Citadel Advisors LLC | 2,184,909 | $31.3M | 0.04% | −14,300−0.7% | Reduced |
| Cormorant Asset Management, LP | 2,286,181 | $32.7M | 2.30% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,663,492 | $52.5M | 0.01% | −479,337−11.6% | Reduced |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,537−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −17,138−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −16,893−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,498−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,591−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |